With an eye to the future and innovation, pharmaceutical company 303 Pharma is launching the amino acid RH-ALFA 1 chain. This is the expression of its founders’ futuristic vision and mission, focused on meeting the needs of an increasingly demanding clientele in search for new products. After many years in the pharmaceutical sector, Marco Benedetti and Liliana Abrami bring a revolutionary product to the national and international market.

Marco Benedetti said: “After gaining experience in the pharmaceuticals market, Liliana and I felt consumers demanded new products. With the experience and knowledge gained in the pharmaceutical sector, we embarked on this adventure, which
gave us great satisfaction. We are the world’s exclusive distributor of the amino acid RH-ALFA 1 chain, which is becoming a must.

What is the new factor that differentiates your product from others on the market?

“The amino acid RH-ALFA 1 chain is extracted from the filament of Japanese silkworms. It is a monohelical recombinant protein which is extremely compatible with human tissue. When it was first suggested to us, Liliana and I fell in love with it so that we started our own revolution in the aesthetic medicine field starting with this Neosilk® recombinant protein. We understood its potential and worked to develop a topical line containing this ingredient, focusing on organic and natural products. 303 Pharma deals with dermaceuticals.”

How will you position yourselves in the market?

“We are strengthening the Italian market, while working for the European and emerging markets such as the Far East and Russia. We have already participated in Arab Health 2019 in Dubai. Recently, we exhibited at the Sies Valet in Bologna, where we found tangible interest in our new product. We are planning attending other events in Europe and the rest of the world, such as Istanbul or the Cosmoprof in Hong Kong.”

Liliana, what gives 303 Pharma its edge?

“We have chosen an ethical approach in developing recognised products, guaranteeing consumers high safety and quality standards. It is no coincidence that our biotechnological collagen has been validated several times and subjected to the necessary tests so that it can be used in other areas and not only
aesthetic skin treatments.”

Speaking of aesthetics, you haven’t overlooked the product range’s glamorous aspects.

“That’s true. We have focused a hundred per cent on quality. We have designed an attractive packaging For our organic and natural product, so that a first glance can reveal the care and attention we have put into the first stage of this revolution.”